National Eye Institute

Leveraging Artificial Intelligence to Prevent Vision Loss From Diabetes

CollaboratorNo phaseNot yet recruiting20266,900 people8 Jan 2025clinicaltrials.gov

NCT05537220

CollaboratorPhase 3Active, not recruiting2023485 people13 Sept 2022clinicaltrials.gov

NCT04661358

CollaboratorPhase 3Active, not recruiting2021563 people10 Dec 2020clinicaltrials.gov

NCT04545736

Phase 1/2Active, not recruiting202055 people11 Sept 2020clinicaltrials.gov

Feasibility Tests for Various Prism Configurations for Visual Field Loss

CollaboratorNo phaseCompleted202010 people11 Jun 2020clinicaltrials.gov

NCT02564978

Phase 2Completed201637 people1 Oct 2015clinicaltrials.gov

NCT02140164

Phase 1/2Completed20147 people16 May 2014clinicaltrials.gov

NCT01675947

Phase 2Terminated201252 people30 Aug 2012clinicaltrials.gov

NCT01517074

Phase 1/2Completed20125 people25 Jan 2012clinicaltrials.gov

NCT01468844

Phase 1/2Completed20116 people10 Nov 2011clinicaltrials.gov

NCT01468831

Phase 1/2Completed20129 people10 Nov 2011clinicaltrials.gov

NCT01445548

Phase 1/2Completed20116 people3 Oct 2011clinicaltrials.gov

NCT01120899

Phase 1/2Completed20106 people11 May 2010clinicaltrials.gov

NCT01003639

CollaboratorPhase 2/3Completed2010165 people29 Oct 2009clinicaltrials.gov

NCT00876434

Phase 1Completed20095 people6 Apr 2009clinicaltrials.gov

NCT00784225

CollaboratorPhase 3Completed200413,475 people3 Nov 2008clinicaltrials.gov

NCT00766649

Phase 1/2Completed200811 people6 Oct 2008clinicaltrials.gov

NCT00711490

Phase 1/2Completed20085 people9 Jul 2008clinicaltrials.gov

NCT00587496

Phase 1Status unknown200660 people7 Jan 2008clinicaltrials.gov

NCT00542178

CollaboratorPhase 3Completed20033,472 people10 Oct 2007clinicaltrials.gov

Roland THEODORE SMITH

R44A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationR44EY0312022021–202722 Sept 2026reporter.nih.gov

Alauddin Bhuiyan

R44A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationR44EY0312022021–202722 Sept 2026reporter.nih.gov

Ihealthscreen, Inc.

R44A Model for Predicting 2-Year Risk of Incident Late Age-related Macular DegenerationR44EY031202US$100k2021–202722 Sept 2026reporter.nih.gov

Peter F Hitchcock

R56Inflammatory mechanisms that regulate neuronal regenerationR56EY0377252026–202819 Sept 2026reporter.nih.gov

University of Michigan at Ann Arbor

R56Inflammatory mechanisms that regulate neuronal regenerationR56EY037725US$1.2m2026–202819 Sept 2026reporter.nih.gov

Johnson Vitharikunnil John

R56Integration and functionality of retinal organoid transplantsR56EY0318342021–202819 Sept 2026reporter.nih.gov

Biju Blavady Thomas

R56Integration and functionality of retinal organoid transplantsR56EY0318342021–202819 Sept 2026reporter.nih.gov

Magdalene J Seiler

R56Integration and functionality of retinal organoid transplantsR56EY0318342021–202819 Sept 2026reporter.nih.gov

University of California-irvine

R56Integration and functionality of retinal organoid transplantsR56EY031834US$1.7m2021–202819 Sept 2026reporter.nih.gov

Pradeep Yammanuru Ramulu

R34Planning a lighting-centered home modification trial to prevent falls in the visually impairedR34EY0382672026–202819 Sept 2026reporter.nih.gov

Xiangrong Kong

R34Planning a lighting-centered home modification trial to prevent falls in the visually impairedR34EY0382672026–202819 Sept 2026reporter.nih.gov

University of Miami School of Medicine

R34Planning a lighting-centered home modification trial to prevent falls in the visually impairedR34EY038267US$479.1k2026–202819 Sept 2026reporter.nih.gov

Evan G Cameron

R01Epigenetic regulation of optic nerve head astrocyte reactivity in glaucomaR01EY0392582026–203118 Sept 2026reporter.nih.gov

Cleveland Clinic Lerner Com-cwru

R01Epigenetic regulation of optic nerve head astrocyte reactivity in glaucomaR01EY039258US$569.7k2026–203118 Sept 2026reporter.nih.gov

Jonathan R Soucy

R00Regulating host neural activity to improve retinal ganglion cell replacement therapiesR00EY0361222026–202917 Sept 2026reporter.nih.gov

University of Wisconsin-madison

R00Regulating host neural activity to improve retinal ganglion cell replacement therapiesR00EY036122US$249k2026–202917 Sept 2026reporter.nih.gov

Jianhai Du

R01Metabolic tuning and signaling in retinal health and diseaseR01EY0396332026–203017 Sept 2026reporter.nih.gov

Jennifer Rayming Chao

R01Metabolic tuning and signaling in retinal health and diseaseR01EY0396332026–203017 Sept 2026reporter.nih.gov

University of Wisconsin-madison

R01Metabolic tuning and signaling in retinal health and diseaseR01EY039633US$609k2026–203017 Sept 2026reporter.nih.gov

Ying Qin

Using a Cataract Model to Investigate Redox Imbalance, Cellular Senescence, and Inflammation in Aging and Age-Related CataractsF31EY03957116 Sept 2026reporter.nih.gov

A genome-scale ORF screen for resilience factors that protect the RPE and restore vision in aged mice

K99EY037340, R01EY031748, R01EY03768230 Sept 2026api.crossref.org

DHA deficiency drives neural oxidized-lipid stress and microglial activation

R01 EY022086, P30 EY016665, R01 EY03051328 Sept 2026api.crossref.org

Myeloid deficiency of RORα exacerbates lipid dysregulation and laser-induced choroidal neovascularization

25 Sept 2026api.crossref.org